Spyre Therapeutics (SYRE) Short Interest Ratio & Short Volume → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free SYRE Stock Alerts $33.09 +0.11 (+0.33%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestTrends Spyre Therapeutics Short Interest DataCurrent Short Interest4,520,000 sharesPrevious Short Interest4,380,000 sharesChange Vs. Previous Month+3.20%Dollar Volume Sold Short$168.96 millionShort Interest Ratio9.5 Days to CoverLast Record DateMay 15, 2024Outstanding Shares40,280,000 sharesFloat Size35,170,000 sharesShort Percent of Float12.85%Today's Trading Volume295,278 sharesAverage Trading Volume423,771 sharesToday's Volume Vs. Average70% Short Selling Spyre Therapeutics ? Sign up to receive the latest short interest report for Spyre Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSYRE Short Interest Over TimeSYRE Days to Cover Over TimeSYRE Percentage of Float Shorted Over Time Ad Chaikin AnalyticsLog Into Marc's $5,000 System TodayNew Panic Could Sweep America Mark these words in 2024. Everyone's going to cash… Wall Street legend says: "A little-known vehicle outside of banks could double… triple… or even quadruple your life savings if you know where to find it right now." We urge you to move your cash into this vehicle in 2024. More here. Spyre Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20244,520,000 shares $168.96 million +3.2%12.9%9.5 $37.38 4/30/20244,380,000 shares $144.67 million +23.0%12.8%8.9 $33.03 4/15/20243,560,000 shares $132.43 million +18.3%10.6%7.3 $37.20 3/31/20243,010,000 shares $114.17 million +4.5%9.4%6 $37.93 3/15/20242,880,000 shares $130.67 million +34.0%9.0%6.4 $45.37 2/29/20242,150,000 shares $59.00 million +35.2%6.7%5.5 $27.44 2/15/20241,590,000 shares $35.87 million +123.6%5.0%5.8 $22.56 1/31/2024711,000 shares $18.42 million No Change2.1%3.8 $25.91 SYRE Short Interest - Frequently Asked Questions What is Spyre Therapeutics' current short interest? Short interest is the volume of Spyre Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 4,520,000 shares of SYRE short. 12.85% of Spyre Therapeutics' shares are currently sold short. Learn More on Spyre Therapeutics' current short interest. What is a good short interest ratio for Spyre Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SYRE shares currently have a short interest ratio of 10.0. Learn More on Spyre Therapeutics's short interest ratio. What is a good short interest percentage for Spyre Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.85% of Spyre Therapeutics' floating shares are currently sold short. Is Spyre Therapeutics' short interest increasing or decreasing? Spyre Therapeutics saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 4,520,000 shares, an increase of 3.2% from the previous total of 4,380,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Spyre Therapeutics' float size? Spyre Therapeutics currently has issued a total of 40,280,000 shares. Some of Spyre Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Spyre Therapeutics currently has a public float of 35,170,000 shares. How does Spyre Therapeutics' short interest compare to its competitors? 12.85% of Spyre Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Spyre Therapeutics: Xencor, Inc. (10.17%), Pacira BioSciences, Inc. (12.98%), Morphic Holding, Inc. (12.34%), Dynavax Technologies Co. (17.34%), Kiniksa Pharmaceuticals, Ltd. (5.62%), Avadel Pharmaceuticals plc (5.91%), Supernus Pharmaceuticals, Inc. (9.33%), Belite Bio, Inc (0.12%), Ligand Pharmaceuticals Incorporated (4.77%), Arcus Biosciences, Inc. (15.70%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Spyre Therapeutics stock? Short selling SYRE is an investing strategy that aims to generate trading profit from Spyre Therapeutics as its price is falling. SYRE shares are trading down $0.91 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Spyre Therapeutics? A short squeeze for Spyre Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SYRE, which in turn drives the price of the stock up even further. How often is Spyre Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SYRE, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Xencor Short Squeeze Pacira BioSciences Short Squeeze Morphic Short Squeeze Dynavax Technologies Short Squeeze Kiniksa Pharmaceuticals Short Squeeze Avadel Pharmaceuticals Short Squeeze Supernus Pharmaceuticals Short Squeeze Belite Bio Short Squeeze Ligand Pharmaceuticals Short Squeeze Arcus Biosciences Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SYRE) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaWARNING about the death of the U.S. dollar…Colonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock Digest Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spyre Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.